AstraZeneca's recent trial failure raises concerns among investors, impacting its share price and fu…
Researchers at King's College London have developed KCL-286, a drug that repairs DNA damage and redu…
Researchers have decoded how bacteria manufacture powerful anti-cancer drugs, paving the way for new…
Anthropic has announced Claude Science, an AI workbench for scientists, and plans to develop its own…
